Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Dihydroquinoxaline and dihydropyridopyrazine derivatives as RSV inhibitors

Dihydroquinoxaline and dihydropyridopyrazine derivatives as RSV inhibitors

US Patent 11534439 · Granted Dec 27, 2022

Estimated economic value: $11,129,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Antiviral heterocyclic compounds2025
Hepatitis B antiviral agents2025
Spiropyrrolidine derived antiviral agents2025
Tetrazole containing apoptosis signal-regulating kinase 1 inhibitors and methods2025
Macrocyclic spiropyrrolidine derived antiviral agents2025
17-beta-hydroxysteroid dehydrogenase type 13 inhibitors and methods of use there2025
Antiviral heterocyclic compounds2025
Antiviral heterocyclic compounds2025
Antiviral heterocyclic compounds2025
Benzodiazepine derivatives as RSV inhibitors2025
Benzodiazepine derivatives as RSV inhibitors2025
Benzodiazepine derivatives as RSV inhibitors2025